NASDAQ · RMTI
Healthcare · Drug Manufacturers - Specialty & Generic
$8.05
Down-$0.04 (-0.49%)
Updated Nov 5, 2026, 2:55 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · RMTI
1M range · 0 trading sessions · Daily adjusted prices
RMTI does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning RMTI.
Company
Market Activity
Research & News
RMTI research
Company profile and research snapshot.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 11, 2026 | HC Wainwright & Co. | Buy | — |
| Jul 9, 2026 | HC Wainwright & Co. | Buy | — |
| Mar 30, 2026 | HC Wainwright & Co. | Buy | — |
| Jan 26, 2026 | HC Wainwright & Co. | Buy | — |
| Nov 13, 2025 | HC Wainwright & Co. | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 15, 2026
WIXOM, Mich., October 15, 2026--Rockwell Medical will release its results for the third quarter ended September 30, 2026 on Thursday, November 12, 2026
Yahoo · Oct 14, 2026
WIXOM, Mich., October 14, 2026--Come visit Rockwell Medical in Booth #1049 at ASN Kidney Week 2026 at the Colorado Convention Center in Denver, CO.
Yahoo · Oct 7, 2026
WIXOM, Mich., October 07, 2026--This marks the 3rd consecutive year that Rockwell Medical earned this recognition—climbing the ranks from #50 (2024) and #40 (2025) to #16 (2026).
Yahoo · Sep 22, 2026
Minot Light Capital Partners, an investment management company, released its Q2 2026 investment letter. A copy of the letter can be downloaded here. In the quarter, the partnership generated gross and net returns of 26.2% and 20.3%, respectively, bringing year-to-date returns to 22.8% gross and 17.1% net. Since inception 21 months ago, gross and net […]
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning RMTI.
